Aktis Oncology, Inc. (AKTS)
NASDAQ·Healthcare·Biotechnology
$16.51
+0.36%
Mkt Cap $884.13M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (7 analysts)
$37.40
Range $35.00 – $40.00
Implied Upside
+126.5%
Consensus $37.40 vs current $16.51
NASDAQ·Healthcare·Biotechnology
$16.51
+0.36%
Mkt Cap $884.13M
Buy
3
Hold
0
Sell
0
Price Target (7 analysts)
$37.40
Range $35.00 – $40.00
+126.5%
Consensus $37.40 vs current $16.51